In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

PE consortium buys Nestle Skin Health for CHF10.2bn; re-brands as Galderma

Executive Summary

Following initial discussions started in May 2019, a private equity consortium--led by EQT VIII fund, and including Luxinva (a subsidiary of Abu Dhabi Investment Authority), PSP Investments, and other institutional investors--acquired Nestle SA's Nestle Skin Health SA (OTC and prescription skin-care), for CHF10.2bn ($10.23bn).
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Buy-out
    • Divestiture/Spin-Out
    • Full Acquisition
    • Payment Includes Cash

Related Companies